{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:50:57Z","timestamp":1786992657342,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jiac-j.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jiac.2017.03.010","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T21:04:02Z","timestamp":1491426242000},"page":"339-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014\u20132015"],"prefix":"10.1016","volume":"23","author":[{"given":"Yoshio","family":"Takesue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kusachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kiyota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Sumiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyasu","family":"Ambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Konosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Hase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Harihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Okabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiko","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ohge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Wakatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2017.03.010_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4058\/jsei.31.335","article-title":"Annual report of JHAIS SSI surveillance (No.17)","volume":"31","author":"Sawa","year":"2016","journal-title":"Jpn J Infect Prev Control"},{"key":"10.1016\/j.jiac.2017.03.010_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1067\/msy.2003.212","article-title":"Surgical complications exert a lasting effect on disease-specific health-related quality of life for patients with colorectal cancer","volume":"134","author":"Anthony","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.jiac.2017.03.010_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/jhin.2001.1003","article-title":"INCISCO Network Study Group. Morbidity and mortality associated with surgical site infections: results from the 1997-1999 INCISO surveillance","volume":"48","author":"Astagneau","year":"2001","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jiac.2017.03.010_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jamcollsurg.2004.05.276","article-title":"Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program","volume":"199","author":"Dimick","year":"2004","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.jiac.2017.03.010_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/501572","article-title":"The impact of surgical-site infection in the 1990s: attribute mortality, excess length of hospitalization, and extra costs","volume":"20","author":"Kirkland","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2017.03.010_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s10156-012-0509-1","article-title":"Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan","volume":"18","author":"Takesue","year":"2012","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib7","doi-asserted-by":"crossref","unstructured":"National Nosocomial Infections Surveillance System. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004; 32: 470\u2013485.","DOI":"10.1016\/j.ajic.2004.10.001"},{"key":"10.1016\/j.jiac.2017.03.010_bib8","series-title":"Performance standards for methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard\u2014tenth edition (M07\u2013A10)","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"key":"10.1016\/j.jiac.2017.03.010_bib9","series-title":"Performance standards for antimicrobial susceptibility testing; Twenty-Sixth edition informational Supplement (M100S)","author":"Clinical and Laboratory Standards Institute","year":"2016"},{"key":"10.1016\/j.jiac.2017.03.010_bib10","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jac\/dkh166","article-title":"Characterization of HMRZ-86. a novel chromogenic cephalosporin for the detection of extended-spectrum beta-lactamases","volume":"53","author":"Hanaki","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10096-005-0074-y","article-title":"Evaluation of a novel kit for the rapid detection of extended-spectrum beta-lactamase","volume":"25","author":"Colodner","year":"2006","journal-title":"Eur J Clin Microb Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jama.2010.1115","article-title":"Active bacterial core surveillance (ABCs) MRSA investigators of the emerging infections program: health care-associated invasive MRSA infections, 2005-2008","volume":"304","author":"Kallen","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2017.03.010_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1469-0691.2010.03262.x","article-title":"Trends among pathogens reported as causing bacteraemia in England, 2004-2008","volume":"17","author":"Wilson","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2017.03.010_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1471-2334-11-151","article-title":"Introduction of an electronic monitoring system for monitoring compliance with Moments 1 and 4 of the WHO \u201cMy 5 Moments for Hand Hygiene\u201d methodology","volume":"11","author":"Cheng","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis","volume":"54","author":"van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10156-010-0086-0","article-title":"Clinical characteristics of vancomycin minimum inhibitory concentration of 2 \u03bcg\/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia","volume":"17","author":"Takesue","year":"2011","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10156-008-0623-2","article-title":"The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility","volume":"14","author":"Niki","year":"2008","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s10156-009-0674-Z","article-title":"Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens' antibacterial susceptibility","volume":"15","author":"Niki","year":"2009","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10156-011-0214-5","article-title":"Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008: general view of the pathogens' antibacterial susceptibility","volume":"17","author":"Niki","year":"2011","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10156-013-0599-4","article-title":"Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"19","author":"Matsumoto","year":"2013","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/381093","article-title":"Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus","volume":"38","author":"Charles","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib22","first-page":"74","article-title":"Antimicrobial susceptibility among E. faecalis and E. faecium from France, Germany, Italy, Spain and the UK (T.E.S.T. Surveillance Study, 2004-2009)","volume":"24","author":"Aznar","year":"2012","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Disease Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib24","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1128\/AAC.05186-14","article-title":"Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013","volume":"59","author":"Lob","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib25","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3201\/eid2211.160519","article-title":"Global Escherichia coli sequence type 131 clade with blaCTX-M-27 Gene","volume":"22","author":"Matsumura","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1469-0691.2009.02893.x","article-title":"Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-nonproducing Escherichia coli isolates","volume":"16","author":"L\u00f3pez-Cerero","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2017.03.010_bib27","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/civ003","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum \u03b2-lactamase bacteremia","volume":"60","author":"Tamma","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"\u03b2-Lactam\/\u03b2-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts","volume":"54","author":"Rodr\u00edguez-Ba\u00f1o","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib29","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/AAC.00135-13","article-title":"Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-\u03b2-lactamase-producing Escherichia coli","volume":"57","author":"Retamar","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1017\/ice.2015.101","article-title":"Carbapenems versus piperacillin-tazobactam for bloodstream infections of nonurinary source caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae","volume":"36","author":"Ofer-Friedman","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2017.03.010_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jiac.2015.02.008","volume":"21","author":"Yanagihara","year":"2015","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jiac.2015.05.014","article-title":"Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases","volume":"21","author":"Ishikawa","year":"2015","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib33","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/653053","article-title":"Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia","volume":"51","author":"Jones","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0732-8893(01)00254-1","article-title":"Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America)","volume":"40","author":"Mathai","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib35","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1086\/341930","article-title":"Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents","volume":"35","author":"Goldstein","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/jac\/dkp005","article-title":"Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study","volume":"63","author":"Montravers","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib37","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1086\/647940","article-title":"Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007)","volume":"50","author":"Snydman","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib38","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/cid\/cir664","article-title":"Clinical efficacy and correlation of clinical outcomes with in\u00a0vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin","volume":"53","author":"Goldstein","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.010_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jac\/dkn134","article-title":"Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece","volume":"62","author":"Papaparaskevas","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jac\/dkg320","article-title":"Emergence of fluoroquinolone resistance among Bacteroides species","volume":"52","author":"Golan","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.03.010_bib41","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/AAC.01435-06","article-title":"National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004","volume":"51","author":"Snydman","year":"2007","journal-title":"Antimicrob Agents Chemother"}],"updated-by":[{"DOI":"10.1016\/j.jiac.2017.11.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000}}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:01:41Z","timestamp":1750179701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17300673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1341321X17300673"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.03.010","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014\u20132015","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}